Healthequity (HQY) Receiving Somewhat Positive News Coverage, Report Shows

Media stories about Healthequity (NASDAQ:HQY) have trended somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Healthequity earned a daily sentiment score of 0.04 on Accern’s scale. Accern also gave news articles about the company an impact score of 46.7046784149258 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

Here are some of the media headlines that may have impacted Accern’s analysis:

Healthequity (HQY) traded down $2.60 during midday trading on Monday, hitting $48.86. The stock had a trading volume of 510,634 shares, compared to its average volume of 522,763. The company has a market cap of $3,112.75, a P/E ratio of 81.68, a P/E/G ratio of 2.26 and a beta of 1.74. Healthequity has a 52-week low of $37.62 and a 52-week high of $55.31.

Healthequity (NASDAQ:HQY) last posted its earnings results on Tuesday, September 5th. The company reported $0.27 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.13. The firm had revenue of $56.90 million during the quarter, compared to the consensus estimate of $55.66 million. Healthequity had a return on equity of 13.93% and a net margin of 20.27%. The company’s quarterly revenue was up 28.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.16 EPS. sell-side analysts predict that Healthequity will post 0.7 earnings per share for the current fiscal year.

Several research firms recently issued reports on HQY. BidaskClub raised shares of Healthequity from a “sell” rating to a “hold” rating in a report on Thursday, September 28th. Zacks Investment Research raised shares of Healthequity from a “hold” rating to a “buy” rating and set a $58.00 target price for the company in a report on Wednesday, October 11th. Oppenheimer reissued a “buy” rating and issued a $61.00 target price on shares of Healthequity in a report on Wednesday, September 6th. Cantor Fitzgerald restated a “buy” rating and issued a $56.00 price target on shares of Healthequity in a research note on Tuesday, August 29th. Finally, Robert W. Baird restated a “hold” rating on shares of Healthequity in a research note on Thursday, September 21st. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $57.50.

In other Healthequity news, VP Ashley Dreier sold 10,000 shares of the stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $45.50, for a total value of $455,000.00. Following the sale, the vice president now owns 15,652 shares in the company, valued at $712,166. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Frank Medici sold 13,000 shares of the stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $52.14, for a total value of $677,820.00. Following the completion of the sale, the director now owns 6,381 shares in the company, valued at approximately $332,705.34. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,743,212 shares of company stock valued at $91,090,651. 19.00% of the stock is owned by corporate insiders.

WARNING: This story was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/04/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-healthequity-hqy-share-price.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply